• Proceedings of the Korean Society of Medical Physics Conference
• /
• 2003.09a
• /
• pp.57-57
• /
• 2003

목적 : 미국 NRC 의 위험도 평가 방법론(NUREG/CR-6642)에 국내에서 시행되는 고선량율 근접치료의 표준입력 자료를 대입하여 고선량율 근접치료시 위험도를 정량적으로 산출하고 그 값을 비교하고자 한다. 대상 및 방법 : 고선량율 근접치료 시스템에 대한 위험도 평가를 위해 국내에서 고선량율 근접치료를 시행하고 있는 17개 의료기관으로부터 방사성동위원소의 설치와 폐기시의 방사능, 선원의 유형, 연간 총 치료회수 등 기초 자료를 수집하였다. 이로부터 방사성동위원소의 평균세기 연간 치료회수 등을 미국 NRC의 위험도 평가 방법론의 데이터베이스에 입력하여 고선량율 근접치료의 직무별, 피폭인의 종류, 정상상태와 사고 등의 형태에 따라 그 위험도를 구하였다. 결과 : 국내 고선량율 근접치료의 위험도는 미국 NRC의 위험도 평가 방법론에 따른 데이터베이스의 입력 결과 일반인의 정상상태와 사고 그리고 방사선종사자의 정상상태와 사고 시에 따라 그 위험도가 1.52-01, 2.96-03, 8.64-01, 3.32-02 rem/yr로 산출되었고 그 값을 미국 NRC의 값과 비교하였다. 결론 : 고선량율 근접치료 시 미국 NRC의 위험도 결과보다는 국내의 경우 수배 정도 높게 계산되었고 일반인과 방사선종사자, 정상상태와 사고, 직무별 패턴 등은 동일한 것으로 간주된다.

• The Journal of Korean Society for Radiation Therapy
• /
• v.12 no.1
• /
• pp.1-7
• /
• 2000

• 대한방사선치료학회:학술대회논문집
• /
• 2000.04a
• /
• pp.6-6
• /
• 2000

• The Journal of Korean Society for Radiation Therapy
• /
• v.5 no.1
• /
• pp.92-94
• /
• 1992

• 대한방사선치료학회:학술대회논문집
• /
• 2001.06a
• /
• pp.8-9
• /
• 2001

• Radiation Oncology Journal
• /
• v.20 no.3
• /
• pp.228-236
• /
• 2002

Purpose : Although high-dose-rate (HDR) brachytherapy regimens have been practiced with a variety of modalities and various degrees of success, few studies on the subject have been conducted. The purpose of this study was to compare the results of local control and late complication rate according to different HDR brachytherapy fractionation regimens in uterine cervical cancer patients. Methods and Materials : From November 1992 to March 1998, 224 patients with uterine conical cancer were treated with external beam irradiation and HDR brachytherapy. In external pelvic radiation therapy, the radiation dose was $45\~54\;Gy$ (median dose 54 Gy) with daily fraction size 1.8 Gy, five times per week. In HDR brachytherapy, 122 patients (Group A) were treated with three times weekly with 3 Gy to line-A (isodose line of 2 cm radius from source) and 102 patients (Group B) underwent the HDR brachytherapy twice weekly with 4 or 4.5 Gy to line-A after external beam irradiation. Iridium-192 was used as the source of HDR brachytherapy. Late complication was assessed from grade 1 to 5 using the RTOG morbidity grading system. Results : The local control rate (LCR) at 5 years was $80\%$ in group A and $84\%$ in group B (p=0.4523). In the patients treated with radiation therapy alone, LCR at 5 years was $60.9\%$ in group A and $76.9\%$ in group B (p=0.2557). In post-operative radiation therapy patients, LCR at 5 years was $92.6\%$ In group A and $91.6\%$ in group B (p=0.8867). The incidence of late complication was $18\%$ (22 patients) and $29.4\%$ (30 patients), of bladder complication was $9.8\%$ (12 patients) and $14.7\%$ (15 patients), and of rectal complication was $9.8\%$ (12 patients) and $21.6\%$ (22 patients), in group A and B, respectively. Lower fraction sized HDR brachytherapy was associated with decrease in late complication (p=0.0405) (rectal complication, p=0.0147; bladder complication, p=0.115). The same result was observed in postoperative radiation therapy patients (p=0.0860) and radiation only treated patients (0=0.0370). Conclusion : For radiation only treated patients, a greater number of itemized studies on the proper fraction size of HDR brachytherapy, with consideration for stages and prognostic factors, are required. In postoperative radiation therapy, the fraction size of HDR brachytherapy did not have much effect on local control, yet the incidence of late complication increased with the elevation in fraction size. We suggest that HDR brachytherapy three times weekly with 3 Gy could be an alternative method of therapy.

• Proceedings of the Korean Society of Medical Physics Conference
• /
• 2003.09a
• /
• pp.58-58
• /
• 2003

목적 : 본 연구에서는 C-arm과 CT에 사용 가능한 자궁경부암용 팬톰을 개발하고 이를 이용하여 기존의 필름 방법에 기반한 위치 확인 방법과 CT 재구성 방법의 정확성을 비교 연구하고자 한다. 정확성이 검증된 후에는 두 방법의 장점을 이용하기 위해 CT로 재구성된 좌표를 필름의 좌표로 변환시켜 현재 사용되고 있는 필름에 기반한 근접 치료 계획 시행에 도움을 주고자 한다. 방법 : 자체 제작한 자궁경부암용 팬톰은 인체 등가 물질인 물과 아크릴을 사용하였고, 크게 localizer 부분과 팬톰 부분으로 구성되어 있다. 또한, 실제 자궁경부암 환자의 임상적인 구조를 모사하여 제작하였다. 자궁경부암 치료시 중요 장기인 방광과 직장을 구와 원기둥으로 설계하였고, 고선량율 applicator는 아크릴 판의 흠으로 고정시켜 제작하였기 때문에 CT 촬영시 applicator를 제거한 영상에서도 applicator의 구조가 정확하게 묘사될 수 있도록 제작하였다. 두 시스템에서 재구성된 좌표를 비교하기 위해 각각의 시스템에서의 얻은 재구성 좌표와 팬톰 자체의 localizer와 재구성 알고리즘을 바탕으로 개발된 프로그램을 이용하여 얻은 좌표로 두 재구성 좌표의 비교 연구를 수행하였다. 정확성이 검증되고 장기의 정보가 담긴 CT의 좌표는 자체 개발된 프로그램으로 2 차원의 필름 좌표로 변환되었다. 본 연구에 사용된 모든 프로그램은 ILD 5.5를 사용하여 개발되었다. 결과 : 두 시스템의 좌표 비교 결과 x, y 축은 차이가 2mm 이내로 비교적 정확한 실험 결과를 얻을 수 있었고, z 축의 경우 CT 슬라이드의 굵기에 따라 2mm-3mm 이내의 차이가 있음을 관찰할 수 있었다. z 축을 제외한 좌표의 차이는 획득한 영상에서 컴퓨터로 좌표를 옮기는 localizer 좌표 선택 과정에 발생했을 것으로 예상된다. 또한, 이 검증된 좌표와 개발된 프로그램을 이용하여 우리는 CT의 좌표를 2차원의 필름 좌표로 정확하게 변환할 수 있었다. 결론 : 이 연구로부터 기존의 C-arm 재구성 방법과 CT 재구성 방법의 비교를 통해 각 치료 기기의 신뢰성을 직접 확인할 수 있었으며, 비교를 통해 검증된 CT의 좌표를 필름 좌표로 변환시킴으로서, 각 시스템의 장점만을 결합한 효과적인 치료 계획을 세울 수 있는 가능성을 제시하였다. 또한 물과 아크릴을 사용한 비교적 간단하고 경제적인 방법으로 C-arm, CT 그리고 MRI에 모두 이용 가능한 팬톰을 제작하여 쉽고 정확하게 위치를 확인할 수 있었다. 더 나아가, 본 연구에서 제작된 자궁경부암 팬톰은 근접치료를 포함하여 관련 팬톰 개발에 도움을 줄 수 있을 것으로 예상된다.

• Radiation Oncology Journal
• /
• v.14 no.2
• /
• pp.123-128
• /
• 1996

Purpose : This is a retrospective study to compare the Palliation rates, survival rates and complications of low dose rate and high dose rate endobronchial brachytherapy in the management of malignant airway obstruction. Materials and methods : Forty three consecutive patients with malignant airway compromise from primary or metastatic lung tumors were treated with low dose rate(LDR) endobronchial Iridium-192 insertion(21 patients) between October 1988 and June 1992, and high dose rate(HDR) endobronchial brachytherapy(22 patients) between August 1992 and April 1994 with palliative aim Flexible fiberoptic bronchoscopy under fluoroscopic control was utilized in all 91 procedures. Twenty seven LDR Procedures delivered a dose of 5-7.5 Gy to a 1.0 cm radius respectively. Results : Subjective and objective responses to treatments were evaluated on follow-up examinations by clinical examination, chest x-rays and CT scan of the chest on some patients. Fifteen of 21 LDR patients and 19 of 22 HDR Patients showed subjective improvement in terms of better breathing and less Productive cough as well as complete disappearance of hemoptysis. Objective improvement on chest x-rays and CT scan of the chest had been demonstrated on 8 LDR Patients and 10 HDR patients. Conclusion : The technique of LDR and HDR endobronchial brachytherapy is simple and well tolerated procedure with minimal morbidity It Provides excellent palliation by keeping airway Patent in these short life-spanned patients.

• Radiation Oncology Journal
• /
• v.20 no.4
• /
• pp.396-404
• /
• 2002

Purpose : Many papers support a correlation between rectal complications and rectal doses in uterine cervical cancer patients treated with radical radiotherapy. In vivo dosimetry in the rectum following the ICRU report 38 contributes to the quality assurance in HDR brachytherapy, especially in minimizing side effects. This study compares the rectal doses calculated in the radiation treatment planning system to that measured with a silicon diode the in vivo dosimetry system. Methods : Nine patients, with a uterine cervical carcinoma, treated with Iridium-192 high dose rate brachytherapy between June 2001 and Feb. 2002, were retrospectively analysed. Six to eight-fractions of high dose rate (HDR)-intracavitary radiotherapy (ICR) were delivered two times per week, with a total dose of $28\~32\;Gy$ to point A. In 44 applications, to the 9 patients, the measured rectal doses were analyzed and compared with the calculated rectal doses using the radiation treatment planning system. Using graphic approximation methods, in conjunction with localization radiographs, the expected dose values at the detector points of an intrarectal semiconductor dosimeter, were calculated. Results : There were significant differences between the calculated rectal doses, based on the simulation radiographs, and the calculated rectal doses, based on the radiographs in each fraction of the HDR ICR. Also, there were significant differences between the calculated and measured rectal doses based on the in-vivo diode dosimetry system. The rectal reference point on the anteroposterior line drawn through the lower end of the uterine sources, according to ICRU 38 report, received the maximum rectal doses in only 2 out of the nine patients $(22.2\%)$. Conclusion : In HDR ICR planning for conical cancer, optimization of the dose to the rectum by the computer-assisted planning system, using radiographs in simulation, is improper. This study showed that in vivo rectal dosimetry, using a diode detector during the HDR ICR, could have a useful role in quality control for HDR brachytherapy in cervical carcinomas. The importance of individual dosimeters for each HDR ICR is clear. In some departments that do not have the in vivo dosimetry system, the radiation oncologist has to find, from lateral fluoroscopic findings, the location of the rectal marker before each fractionated HDR brachytherapy, which is a necessary and important step of HDR brachytherapy for cervical cancer.

• Radiation Oncology Journal
• /
• v.17 no.1
• /
• pp.43-51
• /
• 1999

Purpose : To discuss the technical aspect of interstitial brachytherapy including method of implant, insertion time of radioactive source, total radiation dose, and complication, we reviewed patients who had diagnoses of soft tissue sarcoma and were treated by conservative surgery, interstitial implant and external beam radiation therapy Materials and Methods : Between May 1995 and Dec. 1997, ten patients with primary or recurrent soft tissue sarcoma underwent surgical resection (wide margin excision) and received radiotherapy including interstitial brachytherapy. Catheters were placed with regular intervals of 1 ~l.5 cm immediately after tumor removal and covering the critical structures, such as neurovascular bundle or bone, with gelform, muscle, or tissue expander in the cases where the tumors were close to those structures. Brachytherapy consisted of high dose rate, iridium-192 implant which delivered 12~15 Gy to 1 cm distance from the center of source axis with 2~2.5 Gy/fraction, twice a day, starting on 6th day after the surgery, Within one month after the surgery, total dose of 50~55 Gy was delivered to the tumor bed with wide margin by the external beam radiotherapy. Results : All patients completed planned interstitial brachytherapy without acute side effects directly related with catheter implantation such as infection or bleeding. With median follow up duration of 25 months (range 12~41 months), no local recurrences were observed. And there was no severe form of chronic complication (RTOGIEORTC grade 3 or 4). Conclusion : The high dose rate interstitial brachytherapy is easy and safe way to minimize the radiation dose delivered to the adjacent normal tissue and to decrease radiation induced chronic morbidity such as fibrosis by reducing the total dose of external radiotherapy in the management of soft tissue sarcoma with conservative surgery.